Panbela Therapeutics, Inc.

PBLADelisted Apr 25, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001029125

SEC filings (opens in a new tab)

Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Panbela Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of PBLA: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	17	16	−1
Shares	988.4K	845.3K	−143.1K (−14.5%)
Value	$1.72M	$1.78M	+$63.0K (+3.7%)

New holders (1)

Institutions that held Panbela Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to PBLA in Q1 2022
Institution	Shares	Value	% of portfolio
Geode Capital Management, LLC	13,958	$29.0K	0.00%

Sold out (2)

Institutions that held Panbela Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of PBLA in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Murchinson Ltd.	136,753	$238.0K
Bank of America Corp	22	$0